Skip to main content
OpenTrials
Completed

NCT Number: NCT02348476

A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

This study is a retrospective chart review to assess the tolerability and efficacy of treatment with Simbrinza™ used for patients with Open-Angle Glaucoma or Ocular Hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Open-angle Glaucoma Eye Diseases Glaucoma Glaucoma, Open-Angle Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Wheaton, Illinois, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants treated with Simbrinza™ for Intra-Ocular Pressure (IOP) lowering in at least one eye
  • Participants who had at least one-follow-up visit with tolerablity and efficacy data after Simbrinza™ treatment initiation.

Exclusion criteria

  • Active ocular disease other than glaucoma or ocular hypertension
  • History of any intraocular surgery or glaucoma laser surgery within 3 months.

Treatment and study plan

No intervention

Other

No study drug is administered in this study.

Primary outcomes

  1. The time to first glaucoma therapy escalation occurrence or discontinuation of Simbrinza®

    Time frame: 2 Years

Secondary outcomes

  1. The time to first glaucoma therapy escalation occurrence

    Time frame: 2 Years

  2. The time(s) to additional glaucoma therapy escalation occurrence(s)

    Time frame: 2 Years

  3. Specific AEs and SAEs occurring with a frequency of ≥5%

    Time frame: 2 Years

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jan 28, 2015
Registry last updated
Sep 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.